nach oben

Journal of Cardiovascular Translational Research

Erschienen in:

01.07.2019 | Review Article

The Influence of Sex on Cardiac Physiology and Cardiovascular Diseases

verfasst von: Yu Zhang, Bin Liu, Ranzun Zhao, Saidan Zhang, Xi-yong Yu, Yangxin Li

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Cardiovascular disease (CVD) is the leading cause of death world-wide. Most of treatment strategies were based on studies conducted on male patients. Studies have shown that significant differences exist between the two sexes in the development of CVD. There are certain differences between men and women in the structure and physiological functions of the heart such as left ventricular mass index, resting heart rate, and contractile function. Accordingly, the pathological features of the heart such as the extend of hypertrophy, fibrosis, and remodeling are also different. In addition, different genders also affect clinical symptoms, responses to treatment and prognosis in the development of CVD. Therefore, it is important to take these differences into consideration when design treatment options for men and women.

Nichols, M., Townsend, N., Scarborough, P., & Rayner, M. (2014). Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J, 35(42), 2950–2959. https://doi.org/10.1093/eurheartj/ehu299.CrossRefPubMed

Mosca, L., Ferris, A., Fabunmi, R., & Robertson, R. M. (2004). Tracking women's awareness of heart disease - an American Heart Association National Study. Circulation, 109(5), 573–579. https://doi.org/10.1161/01.Cir.0000115222.69428.C9.CrossRefPubMed

Bundy, J. D., & He, J. (2016). Hypertension and related cardiovascular disease burden in China. Ann Glob Health, 82(2), 227–233. https://doi.org/10.1016/j.aogh.2016.02.002.CrossRefPubMed

Kitzman, D. W., & Edwards, W. D. (1990). Age-related changes in the anatomy of the normal human heart. J Gerontol, 45(2), M33–M39.CrossRefPubMed

Legato, M. J. (2000). Gender and the heart: sex-specific differences in normal anatomy and physiology. J Gend Specif Med, 3(7), 15–18.

Nakata, M., Yada, T., Soejima, N., & Maruyama, I. (1999). Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes, 48(2), 426–429.CrossRefPubMed

Douglas, P. S., Katz, S. E., Weinberg, E. O., Chen, M. H., Bishop, S. P., & Lorell, B. H. (1998). Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol, 32(4), 1118–1125.CrossRefPubMed

Wallner, M., Duran, J. M., Mohsin, S., Troupes, C. D., Vanhoutte, D., Borghetti, G., Vagnozzi, R. J., Gross, P., Yu, D. H., Trappanese, D. M., Kubo, H., Toib, A., Sharp, T. E., Harper, S. C., Volkert, M. A., Starosta, T., Feldsott, E. A., Berretta, R. M., Wang, T., Barbe, M. F., Molkentin, J. D., & Houser, S. R. (2016). Acute catecholamine exposure causes reversible myocyte injury without cardiac regeneration. Circ Res, 119(7), 865–879. https://doi.org/10.1161/Circresaha.116.308687.CrossRefPubMedPubMedCentral

Wang, F., He, Q., Sun, Y., Dai, X., & Yang, X.-P. (2010). Female adult mouse cardiomyocytes are protected against oxidative stress. Hypertension, 55(5), 1172–1178.

10.

Zhu, B. L., Liu, K., Yang, C. Z., Qiao, Y. H., & Li, Z. J. (2016). Gender-related differences in beta-adrenergic receptor-mediated cardiac remodeling. Can J Physiol Pharmacol, 94(12), 1349–1355. https://doi.org/10.1139/cjpp-2016-0103.CrossRefPubMed

11.

Du, X. J., Samuel, C. S., Gao, X. M., Zhao, L., Parry, L. J., & Tregear, G. W. (2003). Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc Res, 57(2), 395–404.CrossRefPubMed

12.

Gillis, A. M. (2017). Atrial fibrillation and ventricular arrhythmias: sex differences in electrophysiology, epidemiology, clinical presentation, and clinical outcomes. Circulation, 135(6), 593–608. https://doi.org/10.1161/CIRCULATIONAHA.116.025312.CrossRefPubMed

13.

Polovina, M. M., Vukicevic, M., Banko, B., Lip, G. Y. H., & Potpara, T. S. (2017). Brugada syndrome: a general cardiologist’s perspective. Eur J Intern Med, 44, 19–27. https://doi.org/10.1016/j.ejim.2017.06.019.CrossRefPubMed

14.

Johnson, B. D., Shaw, L. J., Buchthal, S. D., Bairey Merz, C. N., Kim, H. W., Scott, K. N., Doyle, M., Olson, M. B., Pepine, C. J., den Hollander, J., Sharaf, B., Rogers, W. J., Mankad, S., Forder, J. R., Kelsey, S. F., Pohost, G. M., & National Institutes of Health-National Heart L, Blood I. (2004). Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's ischemia syndrome evaluation (WISE). Circulation, 109(24), 2993–2999. https://doi.org/10.1161/01.CIR.0000130642.79868.B2.CrossRefPubMed

15.

Cho, J. J., Cadet, P., Salamon, E., Mantione, K., & Stefano, G. B. (2003). The nongenomic protective effects of estrogen on the male cardiovascular system: clinical and therapeutic implications in aging men. Med Sci Monit, 9(3), RA63–RA68.

16.

Tweet, M. S., Hayes, S. N., Pitta, S. R., Simari, R. D., Lerman, A., Lennon, R. J., Gersh, B. J., Khambatta, S., Best, P. J., Rihal, C. S., & Gulati, R. (2012). Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation, 126(5), 579–588. https://doi.org/10.1161/CIRCULATIONAHA.112.105718.CrossRefPubMed

17.

Evangelista, O., & McLaughlin, M. A. (2009). Review of cardiovascular risk factors in women. Gend Med, 6(Suppl 1), 17–36. https://doi.org/10.1016/j.genm.2009.02.004.CrossRefPubMed

18.

Zhang, X. H., Lu, Z. L., & Liu, L. (2008). Coronary heart disease in China. Heart, 94(9), 1126–1131. https://doi.org/10.1136/hrt.2007.132423.CrossRefPubMed

19.

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER, 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics C, Stroke Statistics S (2015) Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 131 (4):e29–322. doi:https://doi.org/10.1161/CIR.0000000000000152

20.

Gowd, B. M., & Thompson, P. D. (2012). Effect of female sex on cardiac arrhythmias. Cardiol Rev, 20(6), 297–303. https://doi.org/10.1097/CRD.0b013e318259294b.CrossRefPubMed

21.

Gehi, A. K., Duong, T. D., Metz, L. D., Gomes, J. A., & Mehta, D. (2006). Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis. J Cardiovasc Electrophysiol, 17(6), 577–583. https://doi.org/10.1111/j.1540-8167.2006.00455.x.CrossRefPubMed

22.

Burke, A. P., Farb, A., Malcom, G., & Virmani, R. (2001). Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis. Am Heart J, 141(2 Suppl), S58–S62.CrossRefPubMed

23.

Widder, J., Pelzer, T., von Poser-Klein, C., Hu, K., Jazbutyte, V., Fritzemeier, K. H., Hegele-Hartung, C., Neyses, L., & Bauersachs, J. (2003). Improvement of endothelial dysfunction by selective estrogen receptor-alpha stimulation in ovariectomized SHR. Hypertension, 42(5), 991–996. https://doi.org/10.1161/01.HYP.0000098661.37637.89.CrossRefPubMed

24.

Hodges, Y. K., Tung, L., Yan, X. D., Graham, J. D., Horwitz, K. B., & Horwitz, L. D. (2000). Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation, 101(15), 1792–1798.CrossRefPubMed

25.

Geary, G. G., McNeill, A. M., Ospina, J. A., Krause, D. N., Korach, K. S., & Duckles, S. P. (2001). Selected contribution: cerebrovascular nos and cyclooxygenase are unaffected by estrogen in mice lacking estrogen receptor-alpha. J Appl Physiol, 91(5), 2391–2399; discussion 2389–2390. https://doi.org/10.1152/jappl.2001.91.5.2391.CrossRefPubMed

26.

Mendelsohn, M. E., & Karas, R. H. (1999). The protective effects of estrogen on the cardiovascular system. N Engl J Med, 340(23), 1801–1811. https://doi.org/10.1056/NEJM199906103402306.CrossRefPubMed

27.

Rosano, G. M., Vitale, C., Marazzi, G., & Volterrani, M. (2007). Menopause and cardiovascular disease: the evidence. Climacteric, 10(Suppl 1), 19–24. https://doi.org/10.1080/13697130601114917.CrossRefPubMed

28.

Carmina, E. (2009). Cardiovascular risk and events in polycystic ovary syndrome. Climacteric, 12(Suppl 1), 22–25.CrossRefPubMed

29.

Daan, N. M., Louwers, Y. V., Koster, M. P., Eijkemans, M. J., de Rijke, Y. B., Lentjes, E. W., Fauser, B. C., & Laven, J. S. (2014). Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: Who is really at risk? Fertil Steril, 102(5), 1444–1451 e1443. https://doi.org/10.1016/j.fertnstert.2014.08.001.CrossRefPubMed

30.

Shen, B. J., Avivi, Y. E., Todaro, J. F., Spiro, A., 3rd, Laurenceau, J. P., Ward, K. D., & Niaura, R. (2008). Anxiety characteristics independently and prospectively predict myocardial infarction in men the unique contribution of anxiety among psychologic factors. J Am Coll Cardiol, 51(2), 113–119. https://doi.org/10.1016/j.jacc.2007.09.033.CrossRefPubMed

31.

Shibeshi, W. A., Young-Xu, Y., & Blatt, C. M. (2007). Anxiety worsens prognosis in patients with coronary artery disease. J Am Coll Cardiol, 49(20), 2021–2027. https://doi.org/10.1016/j.jacc.2007.03.007.CrossRefPubMed

32.

Sherwood, A., Blumenthal, J. A., Trivedi, R., Johnson, K. S., O'Connor, C. M., Adams, K. F., Jr., Dupree, C. S., Waugh, R. A., Bensimhon, D. R., Gaulden, L., Christenson, R. H., Koch, G. G., & Hinderliter, A. L. (2007). Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med, 167(4), 367–373. https://doi.org/10.1001/archinte.167.4.367.CrossRefPubMed

33.

Albert, C. M., Chae, C. U., Rexrode, K. M., Manson, J. E., & Kawachi, I. (2005). Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation, 111(4), 480–487. https://doi.org/10.1161/01.CIR.0000153813.64165.5D.CrossRefPubMed

34.

Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., Lisheng, L., & Investigators, I. S. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet, 364(9438), 937–952. https://doi.org/10.1016/S0140-6736(04)17018-9.CrossRefPubMed

35.

Orth-Gomer, K., Wamala, S. P., Horsten, M., Schenck-Gustafsson, K., Schneiderman, N., & Mittleman, M. A. (2000). Marital stress worsens prognosis in women with coronary heart disease: the Stockholm Female Coronary Risk Study. Jama, 284(23), 3008–3014.CrossRefPubMed

36.

Rosengren, A., Hawken, S., Ounpuu, S., Sliwa, K., Zubaid, M., Almahmeed, W. A., Blackett, K. N., Sitthi-amorn, C., Sato, H., Yusuf, S., & investigators I. (2004). Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet, 364(9438), 953–962. https://doi.org/10.1016/S0140-6736(04)17019-0.CrossRefPubMed

37.

Jiang, W., Krishnan, R. R., & O’Connor, C. M. (2002). Depression and heart disease: evidence of a link, and its therapeutic implications. CNS Drugs, 16(2), 111–127. https://doi.org/10.2165/00023210-200216020-00004.CrossRefPubMed

38.

Drory, Y., Kravetz, S., Hirschberger, G., & Israel Study Group on First Acute Myocardial I. (2003). Long-term mental health of women after a first acute myocardial infarction. Arch Phys Med Rehabil, 84(10), 1492–1498.

39.

Barefoot, J. C., Helms, M. J., Mark, D. B., Blumenthal, J. A., Califf, R. M., Haney, T. L., O’Connor, C. M., Siegler, I. C., & Williams, R. B. (1996). Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol, 78(6), 613–617.CrossRefPubMed

40.

Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001). The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care, 24(6), 1069–1078.CrossRefPubMed

41.

Heitzer, T., & Meinertz, T. (2005). Prevention of coronary heart disease: smoking. Z Kardiol, 94(Suppl 3), III/30–III/42. https://doi.org/10.1007/s00392-005-1306-y.CrossRef

42.

Sinha-Hikim, I., Friedman, T. C., Falz, M., Chalfant, V., Hasan, M. K., Espinoza-Derout, J., Lee, D. L., Sims, C., Tran, P., Mahata, S. K., & Sinha-Hikim, A. P. (2017). Nicotine plus a high-fat diet triggers cardiomyocyte apoptosis. Cell Tissue Res, 368(1), 159–170. https://doi.org/10.1007/s00441-016-2536-1.CrossRefPubMed

43.

Huxley, R. R., & Woodward, M. (2011). Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet, 378(9799), 1297–1305.

44.

Yusuf, S., Reddy, S., Ounpuu, S., & Anand, S. (2001). Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation, 104(23), 2855–2864.

45.

He, J., Vupputuri, S., Allen, K., Prerost, M. R., Hughes, J., & Whelton, P. K. (1999). Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. N Engl J Med, 340(12), 920–926. https://doi.org/10.1056/NEJM199903253401204.CrossRefPubMed

46.

Willett, W., Hennekens, C. H., Castelli, W., Rosner, B., Evans, D., Taylor, J., & Kass, E. H. (1983). Effects of cigarette smoking on fasting triglyceride, total cholesterol, and HDL-cholesterol in women. Am Heart J, 105(3), 417–421.CrossRefPubMed

47.

Kotlyar, M., Thuras, P., Hatsukami, D. K., & al’Absi, M. (2017). Sex differences in physiological response to the combination of stress and smoking. Int J Psychophysiol, 118, 27–31. https://doi.org/10.1016/j.ijpsycho.2017.05.008.CrossRefPubMedPubMedCentral

48.

Kearney, P. M., Whelton, M., Reynolds, K., Whelton, P. K., & He, J. (2004). Worldwide prevalence of hypertension: a systematic review. J Hypertens, 22(1), 11–19.

49.

Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005). Global burden of hypertension: analysis of worldwide data. Lancet, 365(9455), 217–223. https://doi.org/10.1016/S0140-6736(05)17741-1.CrossRefPubMed

50.

Dinh, Q. N., Drummond, G. R., Sobey, C. G., & Chrissobolis, S. (2014). Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int, 2014, 406960. https://doi.org/10.1155/2014/406960.CrossRefPubMedPubMedCentral

51.

Ruixing, Y., Jinzhen, W., Shangling, P., Weixiong, L., Dezhai, Y., & Yuming, C. (2008). Sex differences in environmental and genetic factors for hypertension. Am J Med, 121(9), 811–819. https://doi.org/10.1016/j.amjmed.2008.04.026.CrossRefPubMed

52.

Gu, D., Reynolds, K., Wu, X., Chen, J., Duan, X., Muntner, P., Huang, G., Reynolds, R. F., Su, S., Whelton, P. K., He, J., & Inter ACGTICSoCDiA. (2002). Prevalence, awareness, treatment, and control of hypertension in China. Hypertension, 40(6), 920–927.CrossRefPubMed

53.

Hajjar, I., Kotchen, J. M., & Kotchen, T. A. (2006). Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health, 27, 465–490. https://doi.org/10.1146/annurev.publhealth.27.021405.102132.CrossRefPubMed

54.

Gerdts, E., Izzo, R., Mancusi, C., Losi, M. A., Manzi, M. V., Canciello, G., De Luca, N., Trimarco, B., & de Simone, G. (2018). Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network). Int J Cardiol, 258, 257–261. https://doi.org/10.1016/j.ijcard.2017.12.086.CrossRefPubMed

55.

Toedebusch, R., Belenchia, A., & Pulakat, L. (2018). Diabetic cardiomyopathy: impact of biological sex on disease development and molecular signatures. Front Physiol, 9, 453. https://doi.org/10.3389/fphys.2018.00453.CrossRefPubMedPubMedCentral

56.

Regitz-Zagrosek, V., Lehmkuhl, E., & Weickert, M. O. (2006). Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol, 95(3), 136–147.CrossRefPubMed

57.

Barrett-Connor, E. L., Cohn, B. A., Wingard, D. L., & Edelstein, S. L. (1991). Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. Jama, 265(5), 627–631.CrossRefPubMed

58.

Lee, M., Saver, J. L., Towfighi, A., Chow, J., & Ovbiagele, B. (2011). Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis. Atherosclerosis, 217(2), 492–498. https://doi.org/10.1016/j.atherosclerosis.2011.04.020.CrossRefPubMed

59.

Bello, N., & Mosca, L. (2004). Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis, 46(4), 287–295.CrossRefPubMed

60.

Hokanson, J. E., & Austin, M. A. (1996). Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk, 3(2), 213–219.CrossRefPubMed

61.

Reddy Kilim, S., & Chandala, S. R. (2013). A comparative study of lipid profile and oestradiol in pre- and post-menopausal women. J Clin Diagn Res, 7(8), 1596–1598. https://doi.org/10.7860/JCDR/2013/6162.3234.CrossRefPubMedPubMedCentral

62.

Matthews, K. A., Kuller, L. H., Sutton-Tyrrell, K., & Chang, Y. F. (2001). Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke, 32(5), 1104–1111.CrossRefPubMed

63.

Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., Plodkowski, R., & Reviewers of the AACEOCPG. (2016). American Association Of Clinical Endocrinologists And American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract, 22(Suppl 3), 1–203. https://doi.org/10.4158/EP161365.GL.CrossRefPubMed

64.

Hansen, L., Netterstrom, M. K., Johansen, N. B., Ronn, P. F., Vistisen, D., Husemoen, L. L. N., Jorgensen, M. E., Rod, N. H., & Faerch, K. (2017). Metabolically healthy obesity and ischemic heart disease: a 10-year follow-up of the Inter99 Study. J CLIN ENDOCR METAB , 102(6), 1934–1942. https://doi.org/10.1210/jc.2016-3346.CrossRef

65.

Lyall, D. M., Celis-Morales, C., Ward, J., Iliodromiti, S., Anderson, J. J., Gill, J. M. R., Smith, D. J., Ntuk, U. E., Mackay, D. F., Holmes, M. V., Sattar, N., & Pell, J. P. (2017). Association of body mass index with cardiometabolic disease in the UK biobank: a Mendelian randomization study. JAMA Cardiol, 2(8), 882–889. https://doi.org/10.1001/jamacardio.2016.5804.CrossRefPubMedPubMedCentral

66.

Suresh, R., Li, X., Chiriac, A., Goel, K., Terzic, A., Perez-Terzic, C., & Nelson, T. J. (2014). Transcriptome from circulating cells suggests dysregulated pathways associated with long-term recurrent events following first-time myocardial infarction. J Mol Cell Cardiol, 74, 13–21. https://doi.org/10.1016/j.yjmcc.2014.04.017.CrossRefPubMedPubMedCentral

67.

Park, H. W., Kim, K. H., Song, I. G., Kwon, T. G., Kim, W. H., & Bae, J. H. (2017). Body mass index, carotid plaque, and clinical outcomes in patients with coronary artery disease. Coron Artery Dis, 28(4), 278–286. https://doi.org/10.1097/MCA.0000000000000467.CrossRefPubMed

68.

Oyedeji, A. T., Balogun, M. O., Akintomide, A. O., Sunmonu, T. A., Adebayo, R. A., & Ajayi, O. E. (2012). The “obesity paradox” in Nigerians with heart failure. Ann Afr Med, 11(4), 212–216. https://doi.org/10.4103/1596-3519.102851.CrossRefPubMed

69.

Domanski, M. J., Jablonski, K. A., Rice, M. M., Fowler, S. E., Braunwald, E., & Investigators, P. (2006). Obesity and cardiovascular events in patients with established coronary disease. Eur Heart J, 27(12), 1416–1422. https://doi.org/10.1093/eurheartj/ehl022.CrossRefPubMed

70.

Hsich, E., Gorodeski, E. Z., Starling, R. C., Blackstone, E. H., Ishwaran, H., & Lauer, M. S. (2009). Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction. Circulation, 119(25), 3189–U3159. https://doi.org/10.1161/Circulationaha.109.848382.CrossRefPubMedPubMedCentral

71.

Lee, D.-c., Artero, E. G., Sui, X., & Blair, S. N. (2010). Mortality trends in the general population: the importance of cardiorespiratory fitness. J Psychopharmacol, 24(4 Suppl), 27–35.CrossRefPubMedPubMedCentral

72.

Manson, J. E., Greenland, P., LaCroix, A. Z., Stefanick, M. L., Mouton, C. P., Oberman, A., Perri, M. G., Sheps, D. S., Pettinger, M. B., & Siscovick, D. S. (2002). Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med, 347(10), 716–725. https://doi.org/10.1056/NEJMoa021067.CrossRefPubMed

73.

Lakshman, R., Forouhi, N. G., Sharp, S. J., Luben, R., Bingham, S. A., Khaw, K.-T., Wareham, N. J., & Ong, K. K. (2009). Early age at menarche associated with cardiovascular disease and mortality. J Clin Endocrinol Metab, 94(12), 4953–4960.CrossRefPubMed

74.

Canoy, D., Beral, V., Balkwill, A., Wright, F. L., Kroll, M. E., Reeves, G. K., Green, J., Cairns, B. J., Million Women Study, C., Abbiss, H., Abbott, S., Allen, N., Armstrong, M., Balkwill, A., Banks, E., Benson, V., Beral, V., Black, J., Bradbury, K., Brown, A., Cairns, B., Canfell, K., Canoy, D., Crossley, B., Ewart, D., Ewart, S., Fletcher, L., Floud, S., Gathani, T., Gerrard, L., Goodill, A., Green, J., Guiver, L., Lingard, I., Wan Kan, S., Kirichek, O., Kroll, M., Langston, N., Liu, B., Luque, M.-J., Moser, K., Pank, L., Pirie, K., Reeves, G., Shaw, K., Sherman, E., Sherry-Starmer, E., Strange, H., Sweetland, S., Timadjer, A., Tipper, S., Travis, R., Wright, L., Yang, O., Young, H., Banks, E., Beral, V., English, R., Green, J., Patnick, J., Peto, R., Reeves, G., Vessey, M., & Wallis, M. (2015). Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort. Circulation, 131(3), 237–244.CrossRefPubMed

75.

Hutcheon, J. A., Lisonkova, S., & Joseph, K. S. (2011). Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol, 25(4), 391–403. https://doi.org/10.1016/j.bpobgyn.2011.01.006.CrossRef

76.

Juliard, J. M., Golmard, J. L., Himbert, D., Feldman, L. J., Delorme, L., Ducrocq, G., Descoutures, F., Sorbets, E., Garbarz, E., Boudvillain, O., Aubry, P., Vahanian, A., & Steg, P. G. (2013). Comparison of hospital mortality during ST-segment elevation myocardial infarction in the era of reperfusion therapy in women versus men and in older versus younger patients. Am J Cardiol, 111(12), 1708–1713. https://doi.org/10.1016/j.amjcard.2013.02.023.CrossRefPubMed

77.

Bellamy, L., Casas, J. P., Hingorani, A. D., & Williams, D. (2009). Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet, 373(9677), 1773–1779. https://doi.org/10.1016/S0140-6736(09)60731-5.CrossRefPubMed

78.

Carr, D. B., Utzschneider, K. M., Hull, R. L., Tong, J., Wallace, T. M., Kodama, K., Shofer, J. B., Heckbert, S. R., Boyko, E. J., Fujimoto, W. Y., & Kahn, S. E. (2006). Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care, 29(9), 2078–2083. https://doi.org/10.2337/dc05-2482.CrossRefPubMed

79.

Archambault, C., Arel, R., & Filion, K. B. (2014). Gestational diabetes and risk of cardiovascular disease: a scoping review. Open Med, 8(1), e1–e9.

80.

Hedderson, M. M., Darbinian, J., Havel, P. J., Quesenberry, C. P., Sridhar, S., Ehrlich, S., & Ferrara, A. (2013). Low prepregnancy adiponectin concentrations are associated with a marked increase in risk for development of gestational diabetes mellitus. Diabetes Care, 36(12), 3930–3937. https://doi.org/10.2337/dc13-0389.CrossRefPubMedPubMedCentral

81.

Anderson, G. L., Limacher, M., Assaf, A. R., Bassford, T., Beresford, S. A., Black, H., Bonds, D., Brunner, R., Brzyski, R., Caan, B., Chlebowski, R., Curb, D., Gass, M., Hays, J., Heiss, G., Hendrix, S., Howard, B. V., Hsia, J., Hubbell, A., Jackson, R., Johnson, K. C., Judd, H., Kotchen, J. M., Kuller, L., LaCroix, A. Z., Lane, D., Langer, R. D., Lasser, N., Lewis, C. E., Manson, J., Margolis, K., Ockene, J., O'Sullivan, M. J., Phillips, L., Prentice, R. L., Ritenbaugh, C., Robbins, J., Rossouw, J. E., Sarto, G., Stefanick, M. L., Van Horn, L., Wactawski-Wende, J., Wallace, R., Wassertheil-Smoller, S., & Women’s Health Initiative Steering, C. (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. Jama, 291(14), 1701–1712. https://doi.org/10.1001/jama.291.14.1701.CrossRefPubMed

82.

Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007). Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. Jama, 297(13), 1465–1477. https://doi.org/10.1001/jama.297.13.1465.CrossRefPubMed

83.

Hodis, H. N., Mack, W. J., Shoupe, D., Azen, S. P., Stanczyk, F. Z., Hwang-Levine, J., Budoff, M. J., & Henderson, V. W. (2015). Methods and baseline cardiovascular data from the early versus late intervention trial with estradiol testing the menopausal hormone timing hypothesis. Menopause, 22(4), 391–401. https://doi.org/10.1097/GME.0000000000000343.CrossRefPubMedPubMedCentral

84.

Willingham, S. A. M., & Kilpatrick, E. S. (2005). Evidence of gender bias when applying the new diagnostic criteria for myocardial infarction. Heart, 91(2), 237–238. https://doi.org/10.1136/hrt.2004.038497.CrossRefPubMedPubMedCentral

85.

Berg, J., Bjorck, L., Dudas, K., Lappas, G., & Rosengren, A. (2009). Symptoms of a first acute myocardial infarction in women and men. Gend Med, 6(3), 454–462. https://doi.org/10.1016/j.genm.2009.09.007.CrossRefPubMed

86.

Sheifer, S. E., Canos, M. R., Weinfurt, K. P., Arora, U. K., Mendelsohn, F. O., Gersh, B. J., & Weissman, N. J. (2000). Sex differences in coronary artery size assessed by intravascular ultrasound. Am Heart J, 139(4), 649–653.CrossRefPubMed

87.

Lansky, A. J., Hochman, J. S., Ward, P. A., Mintz, G. S., Fabunmi, R., Berger, P. B., New, G., Grines, C. L., Pietras, C. G., Kern, M. J., Ferrell, M., Leon, M. B., Mehran, R., White, C., Mieres, J. H., Moses, J. W., Stone, G. W., Jacobs, A. K., & American College of Cardiology F, American Heart A. (2005). Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation, 111(7), 940–953.CrossRefPubMed

88.

Mickleborough, L. L., Takagi, Y., Maruyama, H., Sun, Z., & Mohamed, S. (1995). Is sex a factor in determining operative risk for aortocoronary bypass graft-surgery. Circulation, 92(9), 80–84. https://doi.org/10.1161/01.Cir.92.9.80.CrossRef

89.

Arnold, A. M., Mick, M. J., Piedmonte, M. R., & Simpfendorfer, C. (1994). Gender differences for coronary angioplasty. Am J Cardiol, 74(1), 18–21.CrossRefPubMed

90.

Ayanian, J. Z., & Epstein, A. M. (1991). Differences in the use of procedures between Women and men hospitalized for coronary heart-disease. New Engl J Med, 325(4), 221–225. https://doi.org/10.1056/Nejm199107253250401.CrossRefPubMed

91.

Bearden, D., Allman, R., McDonald, R., Miller, S., Pressel, S., & Petrovitch, H. (1994). Age, race, and gender variation in the utilization of coronary artery bypass surgery and angioplasty in SHEP. SHEP Cooperative Research Group. Systolic Hypertension in the Elderly Program. J Am Geriatr Soc, 42(11), 1143–1149.CrossRefPubMed

92.

Kelsey, S. F., James, M., Holubkov, A. L., Holubkov, R., Cowley, M. J., & Detre, K. M. (1993). Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute’s Coronary Angioplasty Registry. Circulation, 87(3), 720–727.CrossRefPubMed

93.

Ellis, S. G., Roubin, G. S., King, S. B., 3rd, Douglas, J. S., Jr., Shaw, R. E., Stertzer, S. H., & Myler, R. K. (1988). In-hospital cardiac mortality after acute closure after coronary angioplasty: analysis of risk factors from 8,207 procedures. J Am Coll Cardiol, 11(2), 211–216.CrossRefPubMed

94.

Rosano, G. M., Lewis, B., Agewall, S., Wassmann, S., Vitale, C., Schmidt, H., Drexel, H., Patak, A., Torp-Pedersen, C., Kjeldsen, K. P., & Tamargo, J. (2015). Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC. Eur Heart J, 36(40), 2677–2680. https://doi.org/10.1093/eurheartj/ehv161.CrossRefPubMed

95.

Martinez-Selles, M., Doughty, R. N., Poppe, K., Whalley, G. A., Earle, N., Tribouilloy, C., McMurray, J. J., Swedberg, K., Kober, L., Berry, C., Squire, I., & Meta-Analysis Global Group In Chronic Heart F. (2012). Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail, 14(5), 473–479. https://doi.org/10.1093/eurjhf/hfs026.CrossRefPubMed

96.

Jani, S. M., Montoye, C. K., Chen, B., Roychoudhury, C., & Eagle, K. A. (2005). Gender differences in the application of evidence-based therapies for the treatment of acute myocardial infarction: the American College of Cardiology’s Guidelines Applied in Practice (GAP) projects in Michigan. J Am Coll Cardiol, 45(3), 346a–346a.

97.

Song, X. T., Chen, Y. D., Pan, W. Q., Lu, S. Z., & investigators C. (2007). Gender based differences in patients with acute coronary syndrome: findings from Chinese Registry of Acute Coronary Events (CRACE). Chin Med J, 120(12), 1063–1067.CrossRefPubMed

Titel: The Influence of Sex on Cardiac Physiology and Cardiovascular Diseases
verfasst von: Yu Zhang
Bin Liu
Ranzun Zhao
Saidan Zhang
Xi-yong Yu
Yangxin Li
Publikationsdatum: 01.07.2019
Verlag: Springer US
Erschienen in: Journal of Cardiovascular Translational Research / Ausgabe 1/2020
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-019-09898-x

Neu im Fachgebiet Kardiologie

16.04.2024 | Chronische Herzinsuffizienz | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The Influence of Sex on Cardiac Physiology and Cardiovascular Diseases

Abstract

Neu im Fachgebiet Kardiologie

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Selbstexpandierende TAVI-Klappen bei kleinem Aortenanulus im Vorteil

Verbesserung der HDL-Funktion als Lipidtherapie floppt in Mega-Studie

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Editorial: Gender Differences in Cardiovascular Diseases

Vascular Pathways of Testosterone: Clinical Implications

Gender Differences in Cardiac Hypertrophy

Gender Differences in Prognostic Markers of All-Cause Death in Patients with Acute Heart Failure: a Prospective 18-Month Follow-Up Study

Gender Differences in Arrhythmias: Focused on Atrial Fibrillation

Sex-Specific Aspects in the Pathophysiology and Imaging of Coronary Macro- and Microvascular Disease

Neu im Fachgebiet Kardiologie

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Selbstexpandierende TAVI-Klappen bei kleinem Aortenanulus im Vorteil

Verbesserung der HDL-Funktion als Lipidtherapie floppt in Mega-Studie

Update Kardiologie